FOLH1 and posterior cortical atrophy: Among the PSMA ligands, the small-molecular inhibitor, which shows excellent affinity and sufficient specificity to PSMA, exhibits the most promising effects for PCa diagnosis and treatment (Lenzo et al., 2018).